title: Neuroleptic malignant syndrome during remoxipride treatment. A case report.
abstract: Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication of neuroleptic treatment. The authors describe a case of NMS during treatment with a new atypical neuroleptic, remoxipride. To their knowledge, there are no previously reported cases.
authors.affiliation: Moisio Hospital, Mikkeli, Finland.
authors.forename: H J
authors.initials: HJ
authors.lastname: Koponen
authors.forename: U M
authors.initials: UM
authors.lastname: Lepola
authors.forename: E V
authors.initials: EV
authors.lastname: Leinonen
mesh_terms: D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D017330:Remoxipride / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D017330:Remoxipride